Chatbot Market to Record an Exponential CAGR by 2025| Key Industry Participants WeChat, Varo Money Inc

San Francisco, 25 October 2018: The global chatbot market is expected to reach USD 1.25 billion by 2025, growing at a CAGR of 24.3%, according to a new report by Grand View Research, Inc. The chatbot industry is expected to witness significant growth over the forecast period as they enable enterprises to substantially reduce operating costs. Additionally, innovations in artificial intelligence and machine learning technologies are likely to enhance the features of chatbots, which acts as a major driver for the market.

A significant rise has been observed in the number of users of messaging services, which is expected to surpass the number of users of social networking sites. Additionally, there has been a significant development in the NLP field, which has resulted in streamlined interactions between computers and human languages. The entire chatbot ecosystem comprises various cross-linking features, which facilitates enhanced performance of chatbots in all application. Most companies prefer in-built chatbots on their websites as they facilitate enterprises in providing instant customer interaction. For instance, Slack and Twitter messaging platforms are preferred by majority businesses.

North America is expected to emerge as the major region for the chatbot market over the forecast period. The growth in this region is mainly attributed to the increasing deployment of chatbots in various business verticals. Technologies such as artificial intelligence, IoT, and APIs, among others, are evolving at a rapid speed. Chatbots are integrated with these technologies to offer enhanced operations, thereby driving market demand. Artificial intelligence and audio speech-based chatbots are expected to account for the largest market share in future. Additionally, speech recognition has improved drastically, especially in terms of native languages, which is expected to result in enhanced performance of chatbots in various applications.

Access Research Report of Chatbot Market@ www.grandviewresearch.com/industry-analysis/chatbot-market

Further key findings from the report suggest:

·       Chatbots find various applications in e-commerce, healthcare, and BFSI sectors. Large enterprise emerged as the largest end-user segment in 2016 and is estimated to register a CAGR of 24.2% over the forecast period.

·       The bots for marketing segment is expected to witness the largest growth over the forecast period as these chatbots can connect the customers directly to service providers.

·       The standalone segment is estimated to grow at a CAGR of 24.8% over the forecast period.

·       The Asia Pacific market is projected to witness substantial growth over the next decade owing to various technological developments across major economies. The regional market is expected to grow at a CAGR of 24.7 % from 2017 to 2025.

·       Key participants in the chatbot industry include Baidu, Poncho, Kik, WeChat, Varo Money Inc., Babylon Health, ReplyYes, and SRI International. Chatbots have found wide applications in large enterprises as they enable better understanding of consumer behavior with the help of machine learning.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/communication-services

Grand View Research has segmented the chatbot market based on end users, applications/business models, types, product landscape, verticals, and regions:

End User Outlook (Revenue, USD Million; 2014 - 2025)

·         Small Enterprises

·         Medium Enterprises

·         Large Enterprises

Application/Business Model Outlook (Revenue, USD Million; 2014 - 2025)

·         Bots for Service

·         Bots for Social Media

·         Bots for Payments/Order Processing

·         Bots for Marketing

·         Others

Type Outlook (Revenue, USD Million; 2014 - 2025)

·         Standalone

·         Web-based

·         Messenger-based/Third Party

Product Landscape Outlook (Revenue, USD Million; 2014 - 2025)

·         Artificial Intelligence

·         Marketing

·         Human Intelligence

Vertical Outlook (Revenue, USD Million; 2014 - 2025)

·         Healthcare

·         Retail

·         Banking, Financial Services, and Insurance (BFSI)

·         Media & Entertainment

·         Travel & Tourism

·         E-commerce

·         Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         South America

·         MEA

Access Press Release of Chatbot Market@ www.grandviewresearch.com/press-release/global-chatbot-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Clinical Trial Management System Market Size is Expected to Reach $1.6 Billion by 2025| Key Industry Participants Forte Research Systems, Inc

San Francisco, 25 October 2018: The global clinical trials management system (CTMS) market size is expected to reach USD 1.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 12.1% during the forecast period. Rapid growth of healthcare IT and increasing adoption of CTMS solutions are likely to drive the market. Moreover, heavy investments by various pharmaceutical and biotechnology companies coupled with government funding for R&D is also expected to boost market growth in the coming years.

According to the estimates of International Federation of Pharmaceutical Manufacturers & Associations, research-based pharmaceutical industry has spent around USD 149.8 billion in 2015. Furthermore, the annual spending of the pharmaceutical industry is much higher than other technology industries. This is also estimated to contribute toward the expansion of the market in the years to come.

Access Research Report of Clinical Trial Management System Market @ www.grandviewresearch.com/industry-analysis/clinical-trial-management-system-ctms-market

Further key findings from the study suggest:

·       Increasing R&D investments by healthcare companies coupled with government funding are expected to propel market growth

·       Enterprise CTMS accounted for the largest share in 2016 due to the benefits offered by it, such as real-time insight into the operational activities and helpful tracking in managing the regulatory process

·       Web-based systems contributed towards the largest share in 2016 owing to the benefits offered, such as remote access of data and minimal technical issues. Cloud-based system is anticipated to exhibit the fastest growth over the forecast period. Real-time data tracking, high security, easy accessibility from any device, and privacy are few factors that are attributing towards the segment’s growth

·       Based on region, North America held the largest market share and is expected to retain its dominance during the forecast period. This is attributed to high adoption of advanced technologies and improved infrastructure in the healthcare facilities

·       The Asia Pacific region is likely to witness a significant growth in the next decade due to increasing government incentives and low clinical trial costs

·       Some of the key players in the global market are Surgery Partners; PARAXEL International Corp.; Oracle Corp.; Medidata Solutions, Inc.; Forte Research Systems, Inc.; Medpace Holdings, Inc.; and Clinical Data, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global clinical trials management system market on the basis of type, delivery mode, component, end user, and region:

Clinical Trials Management System Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Enterprise

·         On-site

Clinical Trials Management System Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)

·         Web-based

·         Cloud-based

·         On-premise

Clinical Trials Management System Component Outlook (Revenue, USD Million, 2014 - 2025)

·         Software

·         Services

Clinical Trials Management System End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Pharmaceutical and Biotechnology firm

·         CROs

·         Medical Device Firm

Clinical Trials Management System Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Press Release of Clinical Trial Management System Market@ www.grandviewresearch.com/press-release/global-clinical-trial-management-system-ctms-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Airway Management Devices Market is Expected to Reach $2.1 Billion By 2025|Top Industry Leaders Medtronic, Intersurgical

San Francisco, 24 October 2018: The global airway management devices market is expected to reach USD 2.1 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of chronic respiratory diseases is a high impact rendering growth driver for this market. This increasing prevalence is presumed to be driving the clinical urgency to adopt airway management devices in order to improve the existing ventilation solutions and prevent conditions such as laryngospasms as well as reduce long-term cost associated with the conventional methods.

In addition, advent of new-generation devices that incorporate a wide array of fiber optic, optical, video, and mechanical technologies to facilitate better view of and help management of difficult airways are gaining popularity. For instance, video laryngoscopes, which allow real-time and enhanced visualization, are rapidly becoming first-line measure in emergency care for efficient difficult airway management in hospitals as well as outpatient settings. The benefits of consistent technological advancements include improved optics, better aspiration capabilities, battery-powered light sources, increased angulation capabilities, and improved reprocessing procedures. The aforementioned benefits are anticipated to present the market with lucrative growth opportunities during the forecast period.

Access Research Report of Airway Management Devices Market @ www.grandviewresearch.com/industry-analysis/airway-management-devices-market

Further key findings from the study suggest:

·       Supraglottic segment is expected to exhibit lucrative growth during the forecast period. The exponential growth can be attributed to increasing adoption of laryngeal masks in wide range of clinical applications, such as cardiopulmonary resuscitation and other medical emergencies

·       Emergency medicine is anticipated to exhibit lucrative CAGR during the forecast period owing to increasing significance of these devices in rapid sequence intubation

·       In 2016, North America held a dominant share of the global market as a consequence of local presence of prominent market players working toward extensive commercialization of their product portfolio

·       Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgradation, and increasing healthcare expenditure

·       The key participants such as Ambu A/S, Teleflex, Smiths Medical, Medtronic, Intersurgical, Armstrong Medical Limited and Becton Dickinson and Company are employing sustainability strategies to gain competitive advantage.

·       For instance, in September 2016, Ambu A/S completed the acquisition of ETView Medical Ltd., a medical device manufacturer. The acquisition was carried out to cater unmet patient needs and provide advanced products that allow continuous airway monitoring

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the airway management devices market on the basis of product, application, end use, and region:

Airway Management Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Supraglottic Devices

·         Infraglottic Devices

·         Resuscitators

·         Laryngoscopes

·         Others

Airway Management Devices Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Anesthesia

·         Emergency Medicine

·         Others

Airway Management Devices End-Use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Homecare

·         Others

Airway Management Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Airway Management Devices Market@ www.grandviewresearch.com/press-release/global-airway-management-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Aesthetic Medicine Market is Expected to Reach $11.9 Billion by 2022|Key Industry Participants Solta Medical, Inc. Syneron Medical Ltd

San Francisco, 24 October 2018: The global aesthetic medicine market is expected to reach USD 11.9 billion by 2022, according to a new report by Grand View Research, Inc. Some key drivers of the market include growth in aging population, increasing disposable income, and increasing awareness about the efficacy of aesthetic treatments. 

People aged between 25 to 65 years have prominent aging signs such as wrinkles, fine lines, and dark spots. For instance, according to the CIA World Fact Book, approximately 47.2% of the total population of China was aged between 25 to 54 years in 2014. Growth in geriatric population is likely to boost demand via widening the consumer base. 

Moreover, the need for improved aesthetics in the growing working class population is likely to boost usage rates over the forecast period. For instance, according to sources, the U.S. alone had a working population of 139.206 million in 2011. With improving employment rates especially in the emerging markets, the demand for aesthetic medicine is going to advance over the forecast period. 

However, the presence of stringent regulatory framework to ensure product safety and efficacy is one of the prime factors limiting the growth of the global aesthetic medicine market. Moreover, surgical and minimally invasive procedures require skilled professionals. This coupled with the growing overall treatment cost, is expected to restraint market growth.

Access Research Report of Aesthetic Medicine Market@ www.grandviewresearch.com/industry-analysis/medical-aesthetics-market

Further key findings from the study suggest:

·       Anti-wrinkle products accounted for the largest market share of 50.2% in 2014 owing to high consumer awareness levels regarding product availability, affordable cost, and high efficacy rates

·       The segment is expected to maintain its dominance throughout the forecast period. Minimally invasive technique, lesser side effects, and better results are some factors that are expected to drive the anti-wrinkle market towards expedited growth

·       Botulinum toxin is one of the oldest anti-wrinkle products available in the market. Therefore, awareness about the effectiveness of this product is high as compared to other products, resulting in the segment dominating in terms of revenue share.

·       Hyaluronic acid owing to, low side effects and high efficacy rates also accounted for a large market share in 2014

·       Clinics and beauty centers, was the largest end-use segment in 2014 as majority of the techniques demand skilled professionals to perform the procedure. Moreover, stringent regulatory guidelines limit the use of high-risk devices and treatments to professionals. As a result, the clinics and beauty center segment is expected to maintain its market position throughout the forecast period.

·        Asia pacific accounted for the largest market share of around 32.5% in 2014. Growing penetration of the technologically advanced products, cheaper treatment cost, and presence of skilled professionals are some factors driving regional growth. Moreover, growing popularity of the emerging Asia Pacific countries as medical tourism hubs will boost demand over the forecast period.

·       The presence of a large target population pool in China and India between 25 to 65 years coupled with rapidly increasing disposable income and improving standards of living is spurring the demand for aesthetic medicine in this region.

·       Some key players operating in the global market include Allergan, Inc., Alma Laser, Cynosure, Galderma S.A., Lumenis, Johnson and Johnson, Solta Medical, Inc. and Syneron Medical Ltd. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the aesthetic medicine market on the basis of product type, end-use, and region:

Global Aesthetic Medicine Product Outlook, 2012 - 2022 (USD Million)

·         Energy Based Devices

·         Implants

·         Anti-wrinkle products

Global Aesthetic Medicine End-use Outlook, 2012 - 2022 (USD Million)

·         Clinics and Beauty Centers

·         Home Use

Aesthetic Medicine Regional Outlook, 2012 - 2022 (USD Million)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Aesthetic Medicine Market@ www.grandviewresearch.com/press-release/global-aesthetic-medicine-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com